(CCJ) Cameco - Ratings and Ratios

Exchange: NYSE • Country: Canada • Currency: USD • Type: Common Stock • ISIN: CA13321L1085

Uranium, Nuclear Fuel, Reactor Technology

CCJ EPS (Earnings per Share)

EPS (Earnings per Share) of CCJ over the last years for every Quarter: "2020-03": -0.048570230268976, "2020-06": -0.13390666804779, "2020-09": -0.15352123706236, "2020-12": 0.20166430460715, "2021-03": -0.012414491381134, "2021-06": -0.092435706903445, "2021-09": -0.1812907248009, "2021-12": 0.028223292575014, "2022-03": 0.10092041418638, "2022-06": 0.20994487568905, "2022-09": -0.049026325234227, "2022-12": -0.035658590326194, "2023-03": 0.27377075964718, "2023-06": 0.031505828106521, "2023-09": 0.34030896229667, "2023-12": 0.18450130108587, "2024-03": -0.016251118473556, "2024-06": 0.082600836789371, "2024-09": 0.01705497917212, "2024-12": 0.31045443087288, "2025-03": 0.1601877321969, "2025-06": 0.73680295007738,

CCJ Revenue

Revenue of CCJ over the last years for every Quarter: 2020-03: 345.553, 2020-06: 525.294, 2020-09: 378.87, 2020-12: 550.356, 2021-03: 290.016, 2021-06: 359.205, 2021-09: 361.216, 2021-12: 464.547, 2022-03: 398.038, 2022-06: 557.577, 2022-09: 388.659, 2022-12: 523.729, 2023-03: 686.975, 2023-06: 481.987, 2023-09: 575.079, 2023-12: 843.717, 2024-03: 634, 2024-06: 598.458, 2024-09: 720.596, 2024-12: 1183.173, 2025-03: 789.432, 2025-06: 877.016,

Description: CCJ Cameco

Cameco Corporation is a leading provider of uranium for electricity generation, operating through three segments: Uranium, Fuel Services, and Westinghouse. The companys Uranium segment is involved in exploration, mining, and sale of uranium concentrate, while Fuel Services provides refining, conversion, and fabrication services. Westinghouse, on the other hand, is a nuclear reactor technology original equipment manufacturer, offering products and services to commercial utilities and government agencies.

With a presence in the Americas, Europe, and Asia, Cameco sells its uranium and fuel products to nuclear utilities. The companys diverse customer base and global reach position it for long-term growth. Notably, the nuclear energy sector is experiencing a resurgence due to increasing demand for clean energy sources. Camecos market capitalization stands at approximately $30.9 billion USD, indicating its significant presence in the industry.

To evaluate Camecos performance, key performance indicators (KPIs) such as revenue growth, uranium production costs, and nuclear fuel sales volumes are crucial. The companys ability to maintain a competitive cost structure and increase production volumes will be vital in driving profitability. Additionally, Camecos debt-to-equity ratio and interest coverage ratio are essential metrics to assess its financial health and ability to invest in growth opportunities.

From a valuation perspective, Camecos price-to-earnings (P/E) ratio is around 172.73, indicating a relatively high valuation compared to its current earnings. However, the forward P/E ratio is significantly lower at 68.03, suggesting expected earnings growth in the future. Return on Equity (RoE) stands at 3.94%, which is relatively low, indicating potential for improvement in profitability. Monitoring these KPIs will be essential to understanding Camecos future prospects and making informed investment decisions.

CCJ Stock Overview

Market Cap in USD 34,783m
Sub-Industry Coal & Consumable Fuels
IPO / Inception 1996-03-14

CCJ Stock Ratings

Growth Rating 84.5%
Fundamental 70.8%
Dividend Rating 54.2%
Return 12m vs S&P 500 79.2%
Analyst Rating 4.53 of 5

CCJ Dividends

Dividend Yield 12m 0.16%
Yield on Cost 5y 1.07%
Annual Growth 5y 13.32%
Payout Consistency 94.2%
Payout Ratio 9.3%

CCJ Growth Ratios

Growth Correlation 3m 57.1%
Growth Correlation 12m 51.9%
Growth Correlation 5y 94.6%
CAGR 5y 45.91%
CAGR/Max DD 3y 1.15
CAGR/Mean DD 3y 5.98
Sharpe Ratio 12m 1.06
Alpha 96.33
Beta 0.958
Volatility 43.75%
Current Volume 9653.6k
Average Volume 20d 3648.7k
Stop Loss 82.9 (-4%)
Signal 2.98

Piotroski VR‑10 (Strict, 0-10) 8.5

Net Income (533.6m TTM) > 0 and > 6% of Revenue (6% = 214.2m TTM)
FCFTA 0.09 (>2.0%) and ΔFCFTA 4.42pp (YES ≥ +1.0pp, WARN ≥ +0.5pp)
NWC/Revenue 33.42% (prev 40.30%; Δ -6.89pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp)
CFO/TA 0.12 (>3.0%) and CFO 1.16b > Net Income 533.6m (YES >=105%, WARN >=100%)
Net Debt (279.7m) to EBITDA (1.14b) ratio: 0.25 <= 3.0 (WARN <= 3.5)
Current Ratio 2.96 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active)
Outstanding Shares last Quarter (435.5m) change vs 12m ago -0.10% (target <= -2.0% for YES)
Gross Margin 29.47% (prev 21.64%; Δ 7.83pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0)
Asset Turnover 37.65% (prev 28.26%; Δ 9.40pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0)
Interest Coverage Ratio 7.79 (EBITDA TTM 1.14b / Interest Expense TTM 104.2m) >= 6 (WARN >= 3)

Altman Z'' 4.96

(A) 0.12 = (Total Current Assets 1.80b - Total Current Liabilities 608.9m) / Total Assets 9.58b
(B) 0.36 = Retained Earnings (Balance) 3.49b / Total Assets 9.58b
(C) 0.09 = EBIT TTM 812.1m / Avg Total Assets 9.48b
(D) 2.26 = Book Value of Equity 6.43b / Total Liabilities 2.84b
Total Rating: 4.96 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D)

ValueRay F-Score (Strict, 0-100) 70.77

1. Piotroski 8.50pt = 3.50
2. FCF Yield 1.85% = 0.93
3. FCF Margin 25.25% = 6.31
4. Debt/Equity 0.15 = 2.49
5. Debt/Ebitda 0.87 = 1.93
6. ROIC - WACC -2.22% = -2.78
7. RoE 8.27% = 0.69
8. Rev. Trend 77.05% = 3.85
9. Rev. CAGR 34.44% = 2.50
10. EPS Trend 53.73% = 1.34
11. EPS CAGR 0.0% = 0.0

What is the price of CCJ shares?

As of September 16, 2025, the stock is trading at USD 86.32 with a total of 9,653,607 shares traded.
Over the past week, the price has changed by +11.76%, over one month by +14.18%, over three months by +24.45% and over the past year by +113.08%.

Is Cameco a good stock to buy?

Partly, yes. Based on ValueRay´s Fundamental Analyses, Cameco (NYSE:CCJ) is currently (September 2025) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 70.77 and therefor a somewhat positive outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of CCJ is around 107.46 USD . This means that CCJ is currently undervalued and has a potential upside of +24.49% (Margin of Safety).

Is CCJ a buy, sell or hold?

Cameco has received a consensus analysts rating of 4.53. Therefore, it is recommended to buy CCJ.
  • Strong Buy: 10
  • Buy: 9
  • Hold: 0
  • Sell: 0
  • Strong Sell: 0

What are the forecasts/targets for the CCJ price?

Issuer Target Up/Down from current
Wallstreet Target Price 88.1 2.1%
Analysts Target Price 88.1 2.1%
ValueRay Target Price 120.8 39.9%

Last update: 2025-09-13 05:01

CCJ Fundamental Data Overview

Market Cap CAD = 47.91b (34.78b USD * 1.3775 USD.CAD)
CCE Cash And Equivalents = 263.8m CAD (last quarter)
P/E Trailing = 90.7841
P/E Forward = 54.6448
P/S = 9.7426
P/B = 7.1448
P/EG = 3.33
Beta = 1.223
Revenue TTM = 3.57b CAD
EBIT TTM = 812.1m CAD
EBITDA TTM = 1.14b CAD
Long Term Debt = 996.0m CAD (from longTermDebt, last quarter)
Short Term Debt = unknown (0.0)
Debt = 996.0m CAD (Calculated: Short Term 0.0 + Long Term 996.0m)
Net Debt = 279.7m CAD (from netDebt column, last quarter)
Enterprise Value = 48.65b CAD (47.91b + Debt 996.0m - CCE 263.8m)
Interest Coverage Ratio = 7.79 (Ebit TTM 812.1m / Interest Expense TTM 104.2m)
FCF Yield = 1.85% (FCF TTM 901.3m / Enterprise Value 48.65b)
FCF Margin = 25.25% (FCF TTM 901.3m / Revenue TTM 3.57b)
Net Margin = 14.94% (Net Income TTM 533.6m / Revenue TTM 3.57b)
Gross Margin = 29.47% ((Revenue TTM 3.57b - Cost of Revenue TTM 2.52b) / Revenue TTM)
Tobins Q-Ratio = 7.57 (Enterprise Value 48.65b / Book Value Of Equity 6.43b)
Interest Expense / Debt = 2.25% (Interest Expense 22.4m / Debt 996.0m)
Taxrate = 33.06% (84.9m / 256.7m)
NOPAT = 543.6m (EBIT 812.1m * (1 - 33.06%))
Current Ratio = 2.96 (Total Current Assets 1.80b / Total Current Liabilities 608.9m)
Debt / Equity = 0.15 (Debt 996.0m / last Quarter total Stockholder Equity 6.74b)
Debt / EBITDA = 0.87 (Net Debt 279.7m / EBITDA 1.14b)
Debt / FCF = 1.10 (Debt 996.0m / FCF TTM 901.3m)
Total Stockholder Equity = 6.45b (last 4 quarters mean)
RoA = 5.57% (Net Income 533.6m, Total Assets 9.58b )
RoE = 8.27% (Net Income TTM 533.6m / Total Stockholder Equity 6.45b)
RoCE = 10.90% (Ebit 812.1m / (Equity 6.45b + L.T.Debt 996.0m))
RoIC = 7.17% (NOPAT 543.6m / Invested Capital 7.59b)
WACC = 9.39% (E(47.91b)/V(48.91b) * Re(9.55%)) + (D(996.0m)/V(48.91b) * Rd(2.25%) * (1-Tc(0.33)))
Shares Correlation 3-Years: 65.65 | Cagr: 0.81%
Discount Rate = 9.55% (= CAPM, Blume Beta Adj.)
[DCF Debug] Terminal Value 76.70% ; FCFE base≈727.9m ; Y1≈898.0m ; Y5≈1.53b
Fair Price DCF = 45.72 (DCF Value 19.91b / Shares Outstanding 435.4m; 5y FCF grow 25.0% → 3.0% )
Revenue Correlation: 77.05 | Revenue CAGR: 34.44%
Rev Growth-of-Growth: -0.28
EPS Correlation: 53.73 | EPS CAGR: 0.0%
EPS Growth-of-Growth: 9.52

Additional Sources for CCJ Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle